Journal profile · Dermatology
Annals of Dermatology
ISSN 1013-9087 · eISSN 2005-3894 · Korean Dermatological Association · SOUTH KOREA · Quarterly · Founded 1989
Annals of Dermatology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.86; fully open access; APC about USD 800; median 110 days to acceptance (93 articles, last 24 months); community-reported acceptance: easy; 51 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Annals of Dermatology is published by Korean Dermatological Association and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer and Skin Lesions, Dermatology and Skin Diseases and Genetic and rare skin diseases., together about 23.5% of its articles. Its main subfields are Dermatology. (generated from OpenAlex topic counts and CAS ranking data)
Annals of Dermatology (Ann Dermatol) is the official peer-reviewed publication of the Korean Dermatological Association and the Korean Society for Investigative Dermatology. Since 1989, Ann Dermatol has contributed as a platform for communicating the latest research outcome and recent trend of dermatology in Korea and all over the world. Ann Dermatol seeks for ameliorated understanding of skin and skin-related disease for clinicians and researchers. Ann Dermatol deals with diverse skin-related topics from laboratory investigations to clinical outcomes and invites review articles, original articles, case reports, brief reports and items of correspondence. Ann Dermatol is interested in contributions from all countries in which good and advanced research is carried out. Ann Dermatol willingly recruits well-organized and significant manuscripts with proper scope throughout the world. Readership Annals of Dermatology (Ann Dermatol) is primarily for dermatologists or researchers whose main interests are skin or skin diseases. They can obtain updated information for clinical practice or research. In addition, the readership of Ann Dermatol can be expanded to another positions. Clinicians in the field can access for recent information of skin diseases. Researchers can access for recent trends or topics of researches in skin or skin diseases. Health care providers can access for recent information of skin diseases or skin care. Medical students can access for current trends as well as for interesting cases in dermatology. Policymakers can access for recent informations and data to make new healthcare policies. Editorial correspondence and manuscripts for consideration in the Journal should be submitted online. (https://anndermatol.org or https://www.editorialmanager.com/anndermatol/default.aspx). Ann Dermatol is indexed in Science Citation Index-Expanded, Scopus, KoreaMed, KoreaMed Synapse, KoMCI, Korea Citation Index (KCI), RISS, Crossref.org, and Google Scholar. Business Communications, information on advertising, and questions about subscriptions, should be addressed to the Office of Korean Dermatological Association, 2F, SR Tower, 114, Banpo-daero, Seocho-gu, Seoul 06647, Korea (Tel: 82-70-4639-5200, Fax: 82-2-3472-4203, E-mail: dermajournal@gmail.com). ·
From the journal's Aims & Scope
Research area (LetPub): Dermatology
Editor-in-chief Soyun CHO SeoulPublisher website
Editorial board by country: 2 in mainland China (about 12%); most named United States 6, South Korea 3, Mainland China 2, Japan 2, India 2 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer and Skin LesionsMedicine9.4%
- Dermatology and Skin DiseasesMedicine7.5%
- Genetic and rare skin diseases.Biochemistry, Genetics and Molecular Biology6.7%
- Hair Growth and DisordersMedicine5.3%
- Dermatologic Treatments and ResearchMedicine5.2%
- Nail Diseases and TreatmentsMedicine5%
- Nonmelanoma Skin Cancer StudiesMedicine4.7%
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPubMedPublisher website
Other: Crossref, Google Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.86LetPub ·
- Impact factor (publisher) 2024
- 1.3Publisher website ·
- 5-year impact factor (publisher)
- 1.6Publisher website ·
- CiteScore 2026-06
- 2.2LetPub ·
- CiteScore (publisher)
- 1.4Publisher website ·
- SJR 2026-06
- 0.44LetPub ·
- SJR (publisher)
- 0.38Publisher website ·
- SNIP 2026-06
- 0.68LetPub ·
- SNIP (publisher)
- 0.63Publisher website ·
- h-index
- 30LetPub ·
- h-index
- 63OpenAlex ·
- i10-index
- 998OpenAlex ·
- 2-year mean citedness
- 3.2OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 98.95%LetPub ·
Volume
- Articles per year
- 43LetPub ·
Articles by year OpenAlex count · 3,464 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 59 | 59 | 2 |
| 2025 | 51 | 51 | 133 |
| 2024 | 67 | 67 | 431 |
| 2023 | 188 | 188 | 514 |
| 2022 | 93 | 93 | 456 |
| 2021 | 109 | 109 | 878 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
110 daysMedian, submission to acceptance · P25–P75 67 days – 147 days
- Acceptance to online
- median 36 days (93 articles)
- Submission to online
- median 144 days
- Sample
- 93 articles with submission and acceptance dates (118 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | USD 800 / USD 400 | — | — |
Other charges and waivers (author guidelines)
- Other fees
- Charged; see the journal's website for the amount
- Submission fee
- USD 800
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted10, with length limits
- brief reporteports (not exceeding 1,500 words), and brief reports (brief research reports: not exceeding 1,000 words, brief case reports: not exceeding 500 words). Ann Derm…main text ≤ 1,000 words · references ≤ 10
- brief reportsBrief reports are subcategorized into Research letter and Comments. (Research letter is subject to expert review.)Length not stated
- case reportl articles (not exceeding 3,500 words), case reports (not exceeding 1,500 words), and brief reports (brief research reports: not exceedingmain text ≤ 1,500 words
- editorial1. Authors’ responsibilities - Statement of human and animal right a. For studies on humans (Statement of informed consent and institutional review board approv…Length not stated
- letterropriately tentative terms. b) Research letters should not exceed 1,000 words and 10 references. Two figures or tables are allowed for Remain text ≤ 1,000 words
- meta-analysis- Original Articles a. Original articles include laboratory research as well as clinical research listed below. Clinical trial, meta-analysis, intervention stud…Length not stated
- original article- Original Articles a. Original articles include laboratory research as well as clinical research listed below. Clinical trial, meta-analysis, intervention stud…main text ≤ 3,500 words · figures and tables ≤ 6
- original articlesOriginal articles include laboratory research as well as clinical research listed below. Clinical trial, meta-analysis, intervention study, cohort study, case-c…Length not stated
- review article- Original Articles a. Original articles include laboratory research as well as clinical research listed below. Clinical trial, meta-analysis, intervention stud…main text ≤ 3,500 words · abstract ≤ 250 words
- review articlesReview articles aim to publish comprehensive analyses of recent advances in laboratory or clinical research.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- AI use - Confidentiality and use of artificial intelligence (ai) in peer review
Reviewers should keep manuscripts and the information they contain strictly confidential. Reviewers must not publicly discuss authors’ work and must not appropriate authors’ ideas before the manuscript is published. Reviewers must not retain the manuscript for their personal use and should destroy copies of manuscripts after submitting their reviews. In accordance with ICMJE Recommendations, revie…
Source ↗Publisher website ·- Authorship Authorship
Manuscripts must be written in proper and clear English. Model summary
Ann Dermatol follows the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals by the International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org) and the Good Publication Practice Guidelines for Medical Journals 3rd by the Korean Association of Medical Journal Editors(KAMJE, https://www.kamje.or.kr/board/view?b_name=bo_publi…
Source ↗Publisher website ·- Conflicts of interest Conflicts of Interest
Authors are responsible for disclosing all funding sources that supported their work as well as all institutional or corporate affiliations of the authors. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist currently and over the past 3 years. These include but are not limited to consultant arrangements, stock or other equity ownership, stock options…
Source ↗Publisher website ·- Data availability Data sharing statement
a. Ann Dermatol supports the principle that all data should be made available to facilitate research reproducibility, while protecting patient privacy and confidentiality. We encourage authors to include a data availability statement in the manuscript (eg, a link to a data repository). Authors also have the option to explain why data may not be shared. b. Clinical trials : Ann Dermatol accepts the…
Source ↗Publisher website ·- Publication ethics Article 6. Procedures for Addressing Ethical Misconduct
Upon identifying or suspecting misconduct, the Committee shall collect sufficient information to decide on the infringement, and authors will be given the opportunity to respond to any allegations. In the case of confirmed violations, the following actions may be taken: 1. Issuing a formal letter to the authors regarding the misconduct and providing ethical guidance. 2. Sending an official letter …
Source ↗Publisher website ·- License & copyright Copyright
All authors of accepted manuscripts must sign a copy of the Journal's “Authorship Responsibility and License Agreement” form and submit it to Fax: no. +82-2-3472-4203 or e-mail it to dermajournal@anndermatol.org. For the copyrights of the contributions published in Ann Dermatol (see Creative Commons; Attribution-Noncommercial) at http://creativecommons.org.
Source ↗Publisher website ·- Open access 2. Open Access Policy
Ann Dermatol is an open access journal. Accepted peer-reviewed articles are freely available on the journal website for any user, worldwide, immediately upon publication without additional charge. Articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distrib…
Source ↗Publisher website ·- Peer review 1. Editorial and peer review policy
- Peer review policy and process The Editorial Office of Ann Dermatol reviews all manuscripts received and a manuscript is previewed for its format. If the structure of the manuscript is not sufficient for the instructions in Authors’ guideline, then the manuscript will not accepted. The manuscript which satisfies the basic structural format is sent to Editor-in-Chief for evaluating academic relev…
Source ↗Publisher website ·- Plagiarism Redundant publication and plagiarism
Redundant publication is defined as “reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s).” Characteristics of reports that are substantially similar include the following: (a) “at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant pu…
Source ↗Publisher website ·- Preprints 8. Preprint policy
Ann Dermatol accepts papers submitted in not-for-profit preprint servers (e.g., arXiv, bioRxiv, MedRxiv, or similar platforms). Although the paper’s eligibility to Ann Dermatol will not be limited, its novelty may be undermined if the work is widely recognized through media or other means. Authors posting their preprint work in Ann Dermatol are required to disclose the following policies; 1) Detai…
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting guidelines for specific study designs
Authors are encouraged to consult the reporting guidelines relevant to their specific study design in order not to omit important information. A good source of reporting guidelines is the EQUATOR Network (http://www.equator-network.org/home/) and the United States National Institutes of Health/ National Library of Medicine (http://www.nlm.nih.gov/services/research_report_guide.html).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Korean Dermatological Association
- Country or region
- SOUTH KOREA
- Language
- English
- Frequency
- Quarterly
- Founded
- 1989
- ISSN
- 1013-9087
- Electronic ISSN
- 2005-3894
- Latest issue on the website
- Volume 38, Issue 4 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Annals of Dermatology
What CAS zone is Annals of Dermatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Annals of Dermatology is in Zone 4 of Medicine, and in Zone 4 of the minor category Dermatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Annals of Dermatology?
The latest impact factor listed by LetPub is 1.86; CiteScore 2.2, h-index 63.
How long does peer review take at Annals of Dermatology?
Based on the dates recorded on 93 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 110 days (interquartile range 67–147 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Annals of Dermatology based?
Of the 17 board members whose country the journal's board page names, 2 (about 12%) are in mainland China; the countries named most often are United States (6), South Korea (3) and Mainland China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Annals of Dermatology?
According to LetPub and DOAJ records, Annals of Dermatology is indexed in SCIE and Scopus. The journal's website also lists Web of Science, PMC and PubMed; that list has not been checked against each database.
Is Annals of Dermatology open access, and what is the APC?
Annals of Dermatology is a fully open-access journal. APC about USD 800.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .